ARCHIVES

NCI Cancer Prevention Fellowship Program

This article is from The Cancer Letter archive.

Vol. 26 No. 17 | April 28, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

Murphy Withdraws From SU Position

October 17, 1986

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

In Brief: Bast To Head M.D. Anderson Medicine Dib.; Ozer Named Emory Cancer Center Director

April 8, 1994

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005